ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
DealShare is in sale talks with Truemeds, valuing it at cash on books plus a small premium, with investors receiving Truemeds shares. DealShare raised $393 million, was valued at $1.7 billion in 2022, and revenue fell to Rs 432 crore in FY25. Creator brands Pruf, Curaa, Underneat, and Beastlife raised new funds.
Tap to vote and see what everyone thinks.
Summary by ByteBrief